CLPTM1L/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cells
- 23 November 2018
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 144 (6) , 1367-1378
Abstract
Altered regulation of endoplasmic reticulum (ER) homeostasis has been implicated in many cancers and has recently become a therapeutic and chemosensitization target of interest. We have identified Cleft Lip and Palate Transmembrane 1‐Like (CLPTM1L)/Cisplatin Resistance Related Protein 9 (CRR9) as an ER stress related mediator of cytoprotection in pancreatic cancer. We recently demonstrated that CLPTM1L is highly expressed in pancreatic ductal adenocarcinoma and associated with poor outcome. Furthermore, we have discovered that CLPTM1L interacts with phosphoinositol‐3‐kinase‐alpha at the tumor cell surface and causes up‐regulation of Bcl‐xL and pAkt mediated survival signaling. Here, we demonstrate surface relocalization and survival signaling by CLPTM1L triggered by endoplasmic reticular (ER) stress. We demonstrate the interaction of CLPTM1L with the central ER stress survival mediator, Glucose Regulated Protein 78 (GRP78)/Binding Immunoglobulin Protein (BiP) and PI3K‐alpha /p110α. This interaction and surface relocalization of CLPTM1L and GRP78 is induced by ER stress, including that caused by treatment with gemcitabine. We demonstrate that the extracellular loop of CLPTM1L is required for gemcitabine resistance and interaction with GRP78. This interaction and the chemoresistance effect conferred by this pathway is targetable with our recently developed inhibitory CLPTM1L antibodies, which may represent novel modalities of chemosensitization and treatment of pancreatic adenocarcinoma. Anchorage independent growth, GRP78‐mediated chemoresistance, and Akt phosphorylation were abrogated by inhibition of CLPTM1L. These findings demonstrate a novel and potentially targetable mechanism of cytoprotection and chemoresistance in pancreatic tumors.Keywords
Funding Information
- American Cancer Society (14‐247‐29‐IRG)
- Department of Surgery
- Medical College of Wisconsin
- American Cancer Society (14–247‐29‐IRG)
This publication has 32 references indexed in Scilit:
- The impact of the endoplasmic reticulum protein-folding environment on cancer developmentNature Reviews Cancer, 2014
- Identification of Chemoresistance-Related Cell-Surface Glycoproteins in Leukemia Cells and Functional Validation of Candidate GlycoproteinsJournal of Proteome Research, 2014
- GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblastsBiochemical and Biophysical Research Communications, 2013
- GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapyCell Death & Disease, 2013
- AKTinhibition mitigatesGRP78(glucose‐regulated protein) expression and contribution to chemoresistance in endometrial cancersInternational Journal of Cancer, 2012
- Large-scale Identification of N-Glycosylated Proteins of Mouse Tissues and Construction of a Glycoprotein Database, GlycoProtDBJournal of Proteome Research, 2012
- Regulation of brefeldin A-induced ER stress and apoptosis by mitochondrial NADP+-dependent isocitrate dehydrogenaseBiochemical and Biophysical Research Communications, 2012
- Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cellsLung Cancer, 2011
- GRP78 as potential predictor for breast cancer response to adjuvant taxane therapyInternational Journal of Cancer, 2010
- The Tumor Suppressor Par-4 Activates an Extrinsic Pathway for ApoptosisCell, 2009